首頁 › 頭頸部鱗狀細胞癌 › 北卡羅來納州 › Durham
Durham, NC 的 頭頸部鱗狀細胞癌 臨床試驗
17 項針對 頭頸部鱗狀細胞癌 的研究正在 Durham（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
招募中2/3 期
- Site#0118, Durham
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
招募中1 期
- Exelixis Clinical Site #12, Durham
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
招募中3 期
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 距離 10 英里
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
招募中1/2 期
- University of North Carolina at Chapel Hill, Chapel Hill · 距離 10 英里
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
招募中3 期
- University of North Carolina at Chapel Hill, Chapel Hill · 距離 10 英里
A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma
招募中1 期
- University of North Carolina at Chapel Hill, Chapel Hill · 距離 10 英里
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
招募中2 期
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 距離 10 英里
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
招募中觀察性研究
- UNC- Chapel Hill, Chapel Hill · 距離 10 英里
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
招募中2 期
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 距離 10 英里
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
招募中2/3 期
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 距離 10 英里
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
招募中2 期
- Duke University Medical Center, Durham
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
招募中1 期
- Duke Cancer Institute /ID# 276267, Durham
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
招募中1 期
- Duke Cancer Center /ID# 251975, Durham
Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC
招募中觀察性研究
- University of North Carolina at Chapel Hill, Chapel Hill · 距離 10 英里
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
招募中1 期
- Duke Cancer Institute, Durham
Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy
招募中
- Duke University Medical Center, Durham
A Study of NX-1607 in Adults With Advanced Malignancies
招募中1 期
- University of North Carolina, Chapel Hill · 距離 10 英里
其他城市的 頭頸部鱗狀細胞癌 試驗
- Houston, TX47 項研究
- Los Angeles, CA42 項研究
- Boston, MA40 項研究
- Nashville, TN39 項研究
- New York City, NY39 項研究
- St. Louis, MO28 項研究
- Arlington, VA26 項研究
- Chicago, IL26 項研究
- Philadelphia, PA26 項研究
- Atlanta, GA24 項研究
- San Antonio, TX22 項研究
- Pittsburgh, PA22 項研究
Durham 的其他研究
- 乳癌64 項研究
- 癌症（所有類型）58 項研究
- 非小細胞肺癌39 項研究
- 多發性骨髓瘤37 項研究
- 急性髓系白血病33 項研究
- 轉移性癌症33 項研究
- 前列腺癌32 項研究
- 肺癌32 項研究
- 大腸直腸癌28 項研究
- 卵巢癌27 項研究
- 慢性淋巴性白血病27 項研究
- 心臟衰竭26 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。